APA

Seedhouse C. H., Hunter H. M., Lloyd-Lewis B., Massip A., Pallis M., Carter G. I., Grundy M., Shang S. & Russell N. H. (20070920). DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412. : Leukemia.

Chicago

Seedhouse C H, Hunter H M, Lloyd-Lewis B, Massip A-M, Pallis M, Carter G I, Grundy M, Shang S and Russell N H. 20070920. DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412. : Leukemia.

Harvard

Seedhouse C. H., Hunter H. M., Lloyd-Lewis B., Massip A., Pallis M., Carter G. I., Grundy M., Shang S. and Russell N. H. (20070920). DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412. : Leukemia.

MLA

Seedhouse C H, Hunter H M, Lloyd-Lewis B, Massip A-M, Pallis M, Carter G I, Grundy M, Shang S and Russell N H. DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412. : Leukemia. 20070920.